NovImmune
Series D+NovImmune raised €27M in a Series D+ round in Jan 2016. The company is based in Plan-les-Ouates, Switzerland. Data as of Nov 2026.
Amount raised
€27M
€27,000,000
Native amount
27,000,000 EUR
Stage
Series D+
series f
Investors
0
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €27M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
0 namedNo investors disclosed for this round.
Date
Jan 2016
Round type
series f
Amount (EUR)
€27M